Literature DB >> 1328881

Chemotherapy of lung cancer.

D C Ihde1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1328881     DOI： 10.1056/NEJM199211123272006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

Review 1.  [Role of high-dose chemotherapy in hematology and internal medicine/ oncology].

Authors:  A Engert; A Josting; M Reiser; D Söhngen; V Diehl
Journal:  Med Klin (Munich)       Date:  1999-08-15

2.  Association of patient-provider communication domains with lung cancer treatment.

Authors:  Jenny J Lin; Jessica Lake; Melanie M Wall; Andrew R Berman; John Salazar-Schicchi; Charles Powell; Steven M Keller; Ethan A Halm; Howard Leventhal; Juan P Wisnivesky
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

Review 3.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Authors:  Nishant S Gandhi; Rakesh K Tekade; Mahavir B Chougule
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

4.  Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells.

Authors:  Cheng-Hung Chuang; Li-Yu Wang; Yuen Man Wong; En-Shyh Lin
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

5.  Phase I study of high-dose cisplatin, ifosfamide, and etoposide.

Authors:  E A Perez; P C Sowray; S L Gardner; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Randomized, multi-center phase II trial of docetaxel plus cisplatin versus etoposide plus cisplatin as the first-line therapy for patients with advanced non-small cell lung cancer.

Authors:  Nam-Su Lee; Hee-Sook Park; Jong-Ho Won; Dae-Sik Hong; Su-Taek Uh; Sang-Jae Lee; Joo-Hang Kim; Se-Kyu Kim; Myung-Ju Ahn; Jung-Hye Choi; Suk-Chul Yang; Jung-Ae Lee; Keun-Seok Lee; Chang-Yeol Yim; Yong-Chul Lee; Chul-Soo Kim; Moon-Hee Lee; Kab-Do Jung; Hanlim Moon; Yl-Sub Lee
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

7.  Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?

Authors:  J L Moretti; M Caglar; C Boaziz; N Caillat-Vigneron; J F Morere
Journal:  Eur J Nucl Med       Date:  1995-02

8.  The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.

Authors:  Sujing Liu; Hongbo Guo; Li Kong; Huihui Li; Yan Zhang; Hui Zhu; Jinming Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer.

Authors:  K Eguchi; J Kabe; S Kudo; K Mano; H Morinari; K Nakada; K Noda; Y Saito; T Tanaka; T Uzawa
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy.

Authors:  Chuangzhou Rao; Qiongge Hu; Jianhua Ma; Jian Li; Chen Zhang; Li Shen; Qichun Wei
Journal:  J Exp Clin Cancer Res       Date:  2010-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.